Envestnet Asset Management
TMDX icon

Envestnet Asset Management’s Transmedics TMDX Stock Holding History

Envestnet Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Sell
52,828
-63,718
-55% -$5.39M ﹤0.01% 2727
2026
Q1 		$11.6M Buy
116,546
+73,359
+170% +$9.57M ﹤0.01% 1730
2025
Q4 		$5.25M Sell
43,187
-3,861
-8% -$485K ﹤0.01% 2137
2025
Q3 		$5.28M Buy
47,048
+20,750
+79% +$2.43M ﹤0.01% 2200
2025
Q2 		$3.52M Buy
26,298
+2,933
+13% +$322K ﹤0.01% 2449
2025
Q1 		$1.57M Sell
23,365
-61,007
-72% -$4.2M ﹤0.01% 2892
2024
Q4 		$5.26M Sell
84,372
-5,911
-7% -$550K ﹤0.01% 2069
2024
Q3 		$14.2M Buy
90,283
+15,559
+21% +$2.4M ﹤0.01% 1405
2024
Q2 		$11.3M Sell
74,724
-11,131
-13% -$1.34M ﹤0.01% 1483
2024
Q1 		$6.35M Sell
85,855
-10,696
-11% -$882K ﹤0.01% 1812
2023
Q4 		$7.62M Buy
96,551
+15,799
+20% +$953K ﹤0.01% 1609
2023
Q3 		$4.42M Buy
80,752
+41,168
+104% +$2.96M ﹤0.01% 1881
2023
Q2 		$3.32M Buy
39,584
+8,830
+29% +$676K ﹤0.01% 1953
2023
Q1 		$2.33M Buy
30,754
+2,522
+9% +$174K ﹤0.01% 2101
2022
Q4 		$1.74M Sell
28,232
-7,927
-22% -$421K ﹤0.01% 2262
2022
Q3 		$1.51M Sell
36,159
-21,172
-37% -$921K ﹤0.01% 2258
2022
Q2 		$1.8M Sell
57,331
-9,385
-14% -$250K ﹤0.01% 2171
2022
Q1 		$1.8M Buy
66,716
+12,480
+23% +$224K ﹤0.01% 2263
2021
Q4 		$1.04M Buy
54,236
+949
+2% +$23.8K ﹤0.01% 2612
2021
Q3 		$1.76M Buy
53,287
+5,717
+12% +$175K ﹤0.01% 2170
2021
Q2 		$1.58M Sell
47,570
-405
-0.8% -$11.2K ﹤0.01% 2220
2021
Q1 		$1.99M Buy
47,975
+10,569
+28% +$325K ﹤0.01% 1938
2020
Q4 		$744K Buy
37,406
+14,659
+64% +$217K ﹤0.01% 2447
2020
Q3 		$313K Buy
22,747
+628
+3% +$10.8K ﹤0.01% 2716
2020
Q2 		$396K Sell
22,119
-1,082
-5% -$16.9K ﹤0.01% 2535
2020
Q1 		$280K Buy
23,201
+3,746
+19% +$62.8K ﹤0.01% 2580
2019
Q4 		$370K Buy
+19,455
New +$357K ﹤0.01% 2641

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Envestnet Asset Management's TMDX Position: Q2 2026 in Review

Envestnet Asset Management reduced its Transmedics (TMDX) stake by 55% in Q2 2026, selling an estimated $5.39M and leaving 52,828 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Envestnet Asset Management first reported a position in TMDX in Q4 2019 and has held it in 27 quarters since. The position peaked at $14.2M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Envestnet Asset Management held 52,828 shares of Transmedics worth $3.51M as of Q2 2026.
  • Envestnet Asset Management sold 63,718 Transmedics shares in Q2 2026, an estimated $5.39M.
  • Transmedics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2727 holding.
  • Envestnet Asset Management first reported a position in Transmedics in Q4 2019 and has held it in 27 quarters since.
  • Envestnet Asset Management's Transmedics position peaked at $14.2M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.